Abstract
Significant conservation in cognitive and neurodevelopmental mechanisms exist between Drosophila and mammals. In addition, while mechanisms of aging are relatively well conserved, Drosophila age much faster than mammals. Thus Drosophila are an ideal organism in which to study cognitive and neurodegenerative diseases. Powerful genetic techniques exist that allow genes to be disrupted and overexpressed easily. Phenotypes observed from these mutants can then be used to screen for genetic modifiers to elucidate pathways involved in disease pathology. Here we describe recent advances obtained from Drosophila models for five diseases, neurofibromatosis 1, fragile X syndrome, Alzheimer’s disease, tauopathies, and Parkinson’s disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Margulies C, Tully T, Dubnau J. Deconstructing memory in Drosophila. Curr Biol 2005;15:R700–713.
Mehren JE, Ejima A, Griffith LC. Unconventional sex: Fresh approaches to courtship learning. Curr Opin Neurobiol 2004;14:745–750.
Tully T, et al. A return to genetic dissection of memory in Drosophila. Cold Spring Harb Symp Quant Biol 1996;61:207–218.
Tully T, et al. Genetic dissection of consolidated memory in Drosophila. Cell 1994;79:35–47.
Yin JC, Tully T. CREB and the formation of long-term memory. Curr Opin Neurobiol 1996;6:264–268.
Liebl FL, et al. Genome-wide P-element screen for Drosophila synaptogenesis mutants. J Neurobiol 2006;66:332–347.
Vijayakrishnan N, Broadie K. Temperature-sensitive paralytic mutants: Insights into the synaptic vesicle cycle. Biochem Soc Trans 2006;34:81–87.
Huang FD, et al. Rolling blackout is required for synaptic vesicle exocytosis. J Neurosci 2006;26:2369–2379.
Kidokoro Y. Roles of SNARE proteins and synaptotagmin I in synaptic transmission: Studies at the Drosophila neuromuscular synapse. Neurosignals 2003;12:13–30.
Zhang YQ, et al. Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 2001;107:591–603.
Tong J, et al. Neurofibromin regulates G protein-stimulated adenylyl cyclase activity. Nat Neurosci 2002;5:95–96.
Pan L, et al. The Drosophila fragile X gene negatively regulates neuronal elaboration and synaptic differentiation. Curr Biol 2004; 14:1863–1870.
Tatar M, Bartke A, Antebi A. The endocrine regulation of aging by insulin-like signals. Science 2003;299:1346–1351.
Horiuchi J, Saitoe M. Can flies shed light on our own age-related memory impairment? Ageing Res Rev 2005;4:83–101.
Pletcher SD, Libert S, Skorupa D. Flies and their golden apples: The effect of dietary restriction on Drosophila aging and age-dependent gene expression. Ageing Res Rev 2005;4:451–480.
Longo VD, Finch CE. Evolutionary medicine: From dwarf model systems to healthy centenarians? Science 2003;299:1342–1346.
Fortini ME, et al. A survey of human disease gene counterparts in the Drosophila genome. J Cell Biol 2000;150:F23–30.
Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 1993;118:401–415.
Mao Z, et al. Pharmacogenetic rescue in time and space of the rutabaga memory impairment by using Gene-Switch. Proc Natl Acad Sci USA 2004; 101:198–203.
Osterwalder T, et al. A conditional tissue-specific transgene expression system using inducible GAL4. Proc Natl Acad Sci USA 2001;98:12596–12601.
Rorth P, et al. Systematic gain-of-function genetics in Drosophila. Development 1998;125:1049–1057.
Hay BA, Maile R, Rubin GM. P element insertion-dependent gene activation in the Drosophila eye. Proc Natl Acad Sci USA 1997; 94:5195–5200.
Manev H, Dimitrijevic N, Dzitoyeva S. Techniques: Fruit flies as models for neuropharmacological research. Trends Pharmacol Sci 2003;24:41–43.
Xu GF, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990;62:599–608.
The I, et al. Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science 1997;276:791–794.
Acosta MT, Gioia GA, Silva AJ. Neurofibromatosis type 1: New insights into neurocognitive issues. Curr Neurol Neurosci Rep 2006;6:136–143.
Zhong Y. Mediation of PACAP-like neuropeptide transmission by coactivation of Ras/Raf and cAMP signal transduction pathways in Drosophila. Nature 1995;375:588–592.
Guo HF, et al. Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science 1997;276:795–798.
Guo HF, et al. A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. Nature 2000;403:895–898.
Fieber LA. Ionic currents in normal and neurofibromatosis type 1-affected human Schwann cells: Induction of tumor cell K current in normal Schwann cells by cyclic AMP. J Neurosci Res 1998;54:495–506.
Dasgupta B, Dugan LL, Gutmann DH. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclaseactivating polypeptide-mediated signaling in astrocytes. J Neurosci 2003;23:8949–8954.
Zarnescu DC, et al. Come FLY with us: Toward understanding fragile X syndrome. Genes Brain Behav 2005;4:385–392.
Nimchinsky EA, Oberlander AM, Svoboda K. Abnormal development of dendritic spines in FMR1 knock-out mice. J Neurosci 2001;21:5139–5146.
Grossman AW, et al. Local protein synthesis and spine morphogenesis: Fragile X syndrome and beyond. J Neurosci 2006;26: 7151–7155.
Darnell JC, Mostovetsky O, Darnell RB. FMRP RNA targets: Identification and validation. Genes Brain Behav 2005;4:341–349.
Ule J, Darnell RB. RNA binding proteins and the regulation of neuronal synaptic plasticity. Curr Opin Neurobiol 2006;16:102–110.
Wan L, et al. Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein. Mol Cell Biol 2000;20:8536–8547.
Darnell JC, et al. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 2001;107:489–499.
Brown V, et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 2001;107:477–487.
Reeve SP, et al. The Drosophila fragile X mental retardation protein controls actin dynamics by directly regulating profilin in the brain. Curr Biol 2005;15:1156–1163.
Lee A, et al. Control of dendritic development by the Drosophila fragile X-related gene involves the small GTPase Rac1. Development 2003;130:5543–5552.
Schenck A, et al. A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc Natl Acad Sci USA 2001;98:8844–8849.
Kobayashi K, et al. p140Sra-1 (specifically Rac1-associated protein) is a novel specific target for Rac1 small GTPase. J Biol Chem 1998;273:291–295.
Schenck A, et al. CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein. Neuron 2003;38:887–898.
Eden S, et al. Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature 2002;418:790–793.
Zarnescu DC, et al. Fragile X protein functions with lgl and the par complex in flies and mice. Dev Cell 2005;8:43–52.
Wirtz-Peitz F, Knoblich JA. Lethal giant larvae take on a life of their own. Trends Cell Biol 2006;16:234–241.
Malenka RC, Bear MF. LTP and LTD: An embarrassment of riches. Neuron 2004;44:5–21.
Huber KM, Roder JC, Bear MF. Chemical induction of mGluR5-and protein synthesis-dependent long-term depression in hippocampal area CA1. J Neurophysiol 2001;86:321–325.
Huber KM, et al. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 2002;99:7746–7750.
Bear MF, Huber KM, Warren ST. The mGluR theory of fragile X mental retardation. Trends Neurosci 2004;27:370–377.
Dockendorff TC, et al. Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest. Neuron 2002;34:973–984.
McBride SM, et al. Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 2005;45:753–764.
Blennow K, de Leon MJ, Zetterberg H. Alzheimer’s disease. Lancet 2006;368:387–403.
Tanzi RE, Bertram L. Twenty years of the Alzheimer’s disease amyloid hypothesis: A genetic perspective. Cell 2005;120:545–555.
Sisodia SS, St George-Hyslop PH. gamma-Secretase, Notch, Abeta and Alzheimer’s disease: Where do the presenilins fit in? Nat Rev Neurosci 2002;3:281–290.
Greeve I, et al. Age-dependent neurodegeneration and Alzheimeramyloid plaque formation in transgenic Drosophila. J Neurosci 2004;24:3899–3906.
Iijima K, et al. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: A potential model for Alzheimer’s disease. Proc Natl Acad Sci USA 2004;101:6623–6628.
Crowther DC, et al. Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer’s disease. Neuroscience 2005;132:123–135.
Goedert M, Jakes R. Mutations causing neurodegenerative tauopathies. Biochim Biophys Acta 2005;1739:240–250.
Yen SH, et al. Alzheimer neurofibrillary lesions: Molecular nature and potential roles of different components. Neurobiol Aging 1995;16:381–387.
Wittmann CW, et al. Tauopathy in Drosophila: Neurodegeneration without neurofibrillary tangles. Science 2001;293:711–714.
Jackson GR, et al. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 2002;34:509–519.
Shulman JM, Feany MB. Genetic modifiers of tauopathy in Drosophila. Genetics 2003;165:1233–1242.
Nishimura I, Yang Y, Lu B. PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell 2004;116:671–682.
Doglio LE, et al. gamma-cleavage-independent functions of presenilin, nicastrin, and Aph-1 regulate cell-junction organization and prevent tau toxicity in vivo. Neuron 2006;50:359–375.
Karsten SL, et al. A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tauinduced neurodegeneration. Neuron 2006;51:549–560.
Spillantini MG, et al. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 1998;95:6469–6473.
Spillantini MG, Goedert M. The alpha-synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Ann NY Acad Sci 2000;920:16–27.
Mezey E, et al. Alpha synuclein is present in Lewy bodies in sporadic Parkinson’s disease. Mol Psychiatry 1998;3:493–499.
Polymeropoulos MH, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 1997;276: 2045–2047.
Feany MB, Bender WW. A Drosophila model of Parkinson’s disease. Nature 2000;404:394–398.
Moore DJ, et al. Molecular pathophysiology of Parkinson’s disease. Annu Rev Neurosci 2005;28:57–87.
Park J, et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 2006;441:1157–1161.
Clark IE, et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 2006;441: 1162–1166.
Yang Y, et al. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci USA 2006;103: 10793–10798.
Wang D, et al. Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc Natl Acad Sci USA 2006;103: 13520–13525.
Greene JC, et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA 2003;100:4078–4083.
Auluck PK, et al. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson’s disease. Science 2002; 295:865–868.
Auluck PK, Meulener MC, Bonini NM. Mechanisms of suppression of α-synuclein neurotoxicity by geldanamycin in Drosophila. J Biol Chem 2005;280:2873–2878.
Yang Y, et al. Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron 2003;37: 911–924.
Tamura T, et al. Aging specifically impairs amnesiac-dependent memory in Drosophila. Neuron 2003;40:1003–1011.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Horiuchi, J., Saitoe, M. (2008). Modeling Cognitive and Neurodegenerative Disorders in Drosophila melanogaster . In: Conn, P.M. (eds) Sourcebook of Models for Biomedical Research. Humana Press. https://doi.org/10.1007/978-1-59745-285-4_15
Download citation
DOI: https://doi.org/10.1007/978-1-59745-285-4_15
Publisher Name: Humana Press
Print ISBN: 978-1-58829-933-8
Online ISBN: 978-1-59745-285-4
eBook Packages: MedicineMedicine (R0)